177 related articles for article (PubMed ID: 28299611)
1. Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches.
Prada-Ramallal G; Takkouche B; Figueiras A
Drug Saf; 2017 Jul; 40(7):547-558. PubMed ID: 28299611
[TBL] [Abstract][Full Text] [Related]
2. Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations.
Hammad TA; Pinheiro SP; Neyarapally GA
Clin Trials; 2011 Oct; 8(5):559-70. PubMed ID: 21878445
[TBL] [Abstract][Full Text] [Related]
3. Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: an empirical assessment.
Hammad TA; Neyarapally GA; Pinheiro SP; Iyasu S; Rochester G; Dal Pan G
Clin Trials; 2013; 10(3):389-97. PubMed ID: 23508987
[TBL] [Abstract][Full Text] [Related]
4. A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events.
Faillie JL; Ferrer P; Gouverneur A; Driot D; Berkemeyer S; Vidal X; Martínez-Zapata MJ; Huerta C; Castells X; Rottenkolber M; Schmiedl S; Sabaté M; Ballarín E; Ibáñez L
J Clin Epidemiol; 2017 Jun; 86():168-175. PubMed ID: 28487158
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the limitations of current meta-analysis of randomised controlled trials.
Pogue J; Yusuf S
Lancet; 1998 Jan; 351(9095):47-52. PubMed ID: 9433436
[TBL] [Abstract][Full Text] [Related]
6. The role of meta-analysis in the regulatory process for foods, drugs, and devices.
Berlin JA; Colditz GA
JAMA; 1999 Mar; 281(9):830-4. PubMed ID: 10071005
[TBL] [Abstract][Full Text] [Related]
7. Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities.
Cameron C; Fireman B; Hutton B; Clifford T; Coyle D; Wells G; Dormuth CR; Platt R; Toh S
Syst Rev; 2015 Nov; 4():147. PubMed ID: 26537988
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and effect of publication bias in orthopaedic meta-analyses.
Vavken P; Dorotka R
J Orthop Sci; 2011 Mar; 16(2):238-44. PubMed ID: 21360256
[TBL] [Abstract][Full Text] [Related]
9. The respective roles of controlled clinical trials and cohort monitoring studies in the pre- and postmarketing assessment of drugs.
Vray M; Hamelin B; Jaillon P;
Therapie; 2005; 60(4):339-44, 345-9. PubMed ID: 16268434
[TBL] [Abstract][Full Text] [Related]
10. Publication bias and the efficacy of antidepressants.
Mathew SJ; Charney DS
Am J Psychiatry; 2009 Feb; 166(2):140-5. PubMed ID: 19188290
[No Abstract] [Full Text] [Related]
11. Meta-analyses and overviews of randomised trials.
Richards SM
Blood Rev; 1995 Jun; 9(2):85-91. PubMed ID: 7580394
[TBL] [Abstract][Full Text] [Related]
12. Exploration of heterogeneity in distributed research network drug safety analyses.
Hansen RA; Zeng P; Ryan P; Gao J; Sonawane K; Teeter B; Westrich K; Dubois RW
Res Synth Methods; 2014 Dec; 5(4):352-70. PubMed ID: 26052957
[TBL] [Abstract][Full Text] [Related]
13. Defining, monitoring and combining safety information in clinical trials.
Enas GG; Goldstein DJ
Stat Med; 1995 May 15-30; 14(9-10):1099-111; discussion 1113-6. PubMed ID: 7569503
[TBL] [Abstract][Full Text] [Related]
14. Bayesian methods for design and analysis of safety trials.
Price KL; Xia HA; Lakshminarayanan M; Madigan D; Manner D; Scott J; Stamey JD; Thompson L
Pharm Stat; 2014; 13(1):13-24. PubMed ID: 23897858
[TBL] [Abstract][Full Text] [Related]
15. GRADE guidelines: 5. Rating the quality of evidence--publication bias.
Guyatt GH; Oxman AD; Montori V; Vist G; Kunz R; Brozek J; Alonso-Coello P; Djulbegovic B; Atkins D; Falck-Ytter Y; Williams JW; Meerpohl J; Norris SL; Akl EA; Schünemann HJ
J Clin Epidemiol; 2011 Dec; 64(12):1277-82. PubMed ID: 21802904
[TBL] [Abstract][Full Text] [Related]
16. Drug safety assessment in clinical trials: methodological challenges and opportunities.
Singh S; Loke YK
Trials; 2012 Aug; 13():138. PubMed ID: 22906139
[TBL] [Abstract][Full Text] [Related]
17. A systematic review evaluating the potential for bias and the methodological quality of meta-analyses in vaccinology.
De Vito C; Manzoli L; Marzuillo C; Anastasi D; Boccia A; Villari P
Vaccine; 2007 Dec; 25(52):8794-806. PubMed ID: 18035456
[TBL] [Abstract][Full Text] [Related]
18. Drug-safety pilot makes the grade.
Ledford H
Nature; 2014 Sep; 513(7519):472. PubMed ID: 25254456
[No Abstract] [Full Text] [Related]
19. Diverging Conclusions from the Same Meta-Analysis in Drug Safety: Source of Data (Primary Versus Secondary) Takes a Toll.
Prada-Ramallal G; Takkouche B; Figueiras A
Drug Saf; 2017 Apr; 40(4):351-358. PubMed ID: 28005253
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
